Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$76.05 - $123.38 $88,522 - $143,614
-1,164 Reduced 31.06%
2,584 $207,000
Q1 2022

May 02, 2022

SELL
$108.37 - $120.0 $4,985 - $5,520
-46 Reduced 1.21%
3,748 $424,000
Q4 2021

Jan 27, 2022

SELL
$94.5 - $116.95 $1,417 - $1,754
-15 Reduced 0.39%
3,794 $432,000
Q3 2021

Nov 15, 2021

SELL
$116.26 - $133.78 $1,278 - $1,471
-11 Reduced 0.29%
3,809 $443,000
Q2 2021

Aug 12, 2021

SELL
$105.44 - $127.98 $6,220 - $7,550
-59 Reduced 1.52%
3,820 $460,000
Q1 2021

Apr 29, 2021

SELL
$99.98 - $123.89 $18,396 - $22,795
-184 Reduced 4.53%
3,879 $418,000
Q4 2020

Feb 04, 2021

BUY
$82.82 - $117.4 $15,073 - $21,366
182 Added 4.69%
4,063 $477,000
Q3 2020

Oct 13, 2020

BUY
$79.57 - $91.84 $5,490 - $6,336
69 Added 1.81%
3,881 $332,000
Q2 2020

Aug 13, 2020

BUY
$65.52 - $88.28 $249,762 - $336,523
3,812 New
3,812 $302,000

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $13.5B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.